Importantly, SG5 acted through the GLP-1/PGC-1α signaling pathway, which plays a crucial role in neuroprotection and mitochondrial function, offering another promising probiotic-based therapeutic approach for PD [72]. This evidence concerns the gene PPARGC1A and Parkinson disease.